Providence Capital Advisors, LLC Liquidia Corp Transaction History
Providence Capital Advisors, LLC
- $445 Million
- Q1 2024
A detailed history of Providence Capital Advisors, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 19 shares of LQDA stock, worth $228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$228% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
157Shares Held
35.5MCall Options Held
1.68MPut Options Held
1.17M-
Patient Square Capital LP Menlo Park, CA7.18MShares$86.2 Million45.11% of portfolio
-
Black Rock Inc. New York, NY3.75MShares$45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$34.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.25MShares$27 Million3.48% of portfolio
-
Findell Capital Management LLC New York, NY2.11MShares$25.3 Million16.28% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $772M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...